AU2001256595A1 - Novel amorphous form of sertraline hydrochloride - Google Patents

Novel amorphous form of sertraline hydrochloride

Info

Publication number: AU2001256595A1
Authority: AU; Australia
Prior art keywords: amorphous form; sertraline hydrochloride; novel amorphous; novel; sertraline
Prior art date: 2000-05-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001256595A

Other languages

English (en)

Inventor

Brij Khera

Yatendra Kumar

Amit Rohatgi

Om Dutt Tyagi

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ranbaxy Laboratories Ltd

Original Assignee

Ranbaxy Laboratories Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-26

Filing date

2001-05-24

Publication date

2001-12-03

2001-05-24 Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd

2001-12-03 Publication of AU2001256595A1 publication Critical patent/AU2001256595A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
- C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Psychiatry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AU2001256595A 2000-05-26 2001-05-24 Novel amorphous form of sertraline hydrochloride Abandoned AU2001256595A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IN540/DEL/2000		2000-05-26
IN540DE2000 IN192343B (sv)	2000-05-26	2000-05-26
PCT/IB2001/000909 WO2001090049A1 (en)	2000-05-26	2001-05-24	Novel amorphous form of sertraline hydrochloride

Publications (1)

Publication Number	Publication Date
AU2001256595A1 true AU2001256595A1 (en)	2001-12-03

Family

ID=11097055

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001256595A Abandoned AU2001256595A1 (en)	2000-05-26	2001-05-24	Novel amorphous form of sertraline hydrochloride

Country Status (11)

Country	Link
US (1)	US20040063792A1 (sv)
EP (1)	EP1289928A4 (sv)
JP (1)	JP2003534310A (sv)
CN (1)	CN1438989A (sv)
AU (1)	AU2001256595A1 (sv)
BR (1)	BR0111193A (sv)
CA (1)	CA2409856A1 (sv)
CZ (1)	CZ20023903A3 (sv)
IN (1)	IN192343B (sv)
SK (1)	SK17272002A3 (sv)
WO (1)	WO2001090049A1 (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6500987B1 (en)	1998-11-27	2002-12-31	Teva Pharmaceutical Industries Ltd.	Sertraline hydrochloride polymorphs
US6495721B1 (en)	1999-08-09	2002-12-17	Teva Pharmaceutical Industries Ltd.	Sertraline hydrochloride Form II and methods for the preparation thereof
PT1248605E (pt)	1999-12-21	2007-03-30	Teva Pharma	Novos polimorfos de cloridrato de sertralina, processos para a sua preparação, composições que os contêm e métodos para a sua utilização
US7067700B2 (en)	2001-05-31	2006-06-27	Fermion Oy	Process for preparing sertraline hydrochloride polymorphic form II
AU2003251290A1 (en)	2002-04-29	2003-11-17	Teva Pharmaceutical Industries Ltd.	Process for preparation of polymorphic form ii of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof
WO2005000786A1 (en)	2003-05-23	2005-01-06	Transform Pharmaceuticals, Inc.	Sertraline compositions
US7173153B2 (en) *	2003-07-15	2007-02-06	Recordati Industria Chimica E. Farmaceutica S.P.A.	Sertraline hydrochloride form II and methods for the preparation thereof
EP1648854A1 (en)	2003-07-15	2006-04-26	RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.a.	Methods for preparing sertraline hydrochloride polymorphs
EP1776049A2 (en) *	2005-01-27	2007-04-25	Teva Pharmaceutical Industries Ltd.	Duloxetine hcl polymorphs
US8158152B2 (en) *	2005-11-18	2012-04-17	Scidose Llc	Lyophilization process and products obtained thereby
DE102008039271A1 (de) *	2007-12-23	2009-06-25	Euromed Sa	Neuer Mariendistelextrakt, Verfahren zur Herstellung und Verwendung
HUE048016T2 (hu)	2011-01-21	2020-05-28	Avery Dennison Corp	Klórhexidin-glükonátot tartalmazó ragasztó
US11058793B2 (en)	2011-05-16	2021-07-13	Avery Dennison Corporation	Adhesive containing microparticles
WO2014124232A2 (en)	2013-02-07	2014-08-14	Avery Dennison Corporation	Antimicrobial adhesives having improved properties
EP2968014B1 (en)	2013-03-15	2019-04-24	Avery Dennison Corporation	Transparent cover dressing application system and inclusion of label strip
WO2015188031A2 (en)	2014-06-05	2015-12-10	Avery Dennison Corporation	Articles with active agent concentrated at the substrate contacting surface and related methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4536518A (en) *	1979-11-01	1985-08-20	Pfizer Inc.	Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US5166437A (en) *	1989-03-03	1992-11-24	Orion-Yhtyma Oy	Process for the preparation of fluoxetine
US5248699A (en) *	1992-08-13	1993-09-28	Pfizer Inc.	Sertraline polymorph
US5734083A (en) *	1996-05-17	1998-03-31	Torcan Chemical Ltd.	Sertraline polymorph
JP2000026378A (ja) *	1998-07-03	2000-01-25	Sumika Fine Chemicals Co Ltd	塩酸セルトラリンの製法
US6500987B1 (en) *	1998-11-27	2002-12-31	Teva Pharmaceutical Industries Ltd.	Sertraline hydrochloride polymorphs
HK1040979A1 (zh) *	1998-11-27	2002-06-28	Teva Pharmaceutical Industries Ltd.	鹽酸舍曲林多晶型物
TWI260315B (en) *	1999-10-29	2006-08-21	Ciba Sc Holding Ag	Polymorphic forms of sertraline hydrochloride

2000
- 2000-05-26 IN IN540DE2000 patent/IN192343B/en unknown
2001
- 2001-05-24 US US10/296,455 patent/US20040063792A1/en not_active Abandoned
- 2001-05-24 WO PCT/IB2001/000909 patent/WO2001090049A1/en not_active Application Discontinuation
- 2001-05-24 SK SK1727-2002A patent/SK17272002A3/sk unknown
- 2001-05-24 CA CA002409856A patent/CA2409856A1/en not_active Abandoned
- 2001-05-24 BR BR0111193-0A patent/BR0111193A/pt not_active Application Discontinuation
- 2001-05-24 CZ CZ20023903A patent/CZ20023903A3/cs unknown
- 2001-05-24 EP EP01929918A patent/EP1289928A4/en not_active Withdrawn
- 2001-05-24 JP JP2001586239A patent/JP2003534310A/ja active Pending
- 2001-05-24 AU AU2001256595A patent/AU2001256595A1/en not_active Abandoned
- 2001-05-24 CN CN01812018A patent/CN1438989A/zh active Pending

Also Published As

Publication number	Publication date
IN192343B (sv)	2004-04-10
JP2003534310A (ja)	2003-11-18
US20040063792A1 (en)	2004-04-01
CN1438989A (zh)	2003-08-27
WO2001090049A1 (en)	2001-11-29
EP1289928A4 (en)	2005-06-08
BR0111193A (pt)	2003-07-29
SK17272002A3 (sk)	2003-05-02
CZ20023903A3 (cs)	2003-05-14
CA2409856A1 (en)	2001-11-29
EP1289928A1 (en)	2003-03-12

Publication	Publication Date	Title
AU2002219555A1 (en)	2003-01-23	VLA-4 Inhibitors
AU2001241128A1 (en)	2001-09-24	Novel amide compounds
AU2001244399A1 (en)	2001-10-23	Gamma-secretase inhibitors
AUPR034000A0 (en)	2000-10-19	Aminoalcohol derivatives
AUPQ841300A0 (en)	2000-07-20	New aminoalcohol derivatives
AU1386301A (en)	2001-05-14	Polymorphic forms of sertraline hydrochloride
AU2001256595A1 (en)	2001-12-03	Novel amorphous form of sertraline hydrochloride
AUPQ585000A0 (en)	2000-03-16	Aminoalcohol derivatives
AU1234002A (en)	2002-05-15	Crystalline forms of venlafaxine hydrochloride
AU2001281965A1 (en)	2002-01-30	Novel 6-phenylphenanthridines
AU2001240095A1 (en)	2001-09-17	Polarization transformer
AU2002218215A1 (en)	2002-04-22	Novel pleuromutilin derivatives
AU2001248788A1 (en)	2001-11-07	Glucuronofucan sulfate
AU4604000A (en)	2000-12-12	Amorphous form of fexofenadine hydrochloride
AU2001296612A1 (en)	2002-04-15	Flywheel
AU2001268853A1 (en)	2002-01-02	Biocatalyst inhibitors
AU2002241600A1 (en)	2002-06-18	Nitrile process
EP1238585B8 (de)	2005-07-06	Verwendung von Esterquats
AU2002353803A1 (en)	2003-04-22	Direct resolution of racemic threo-methylphenidate hydrochloride
AU2001258330A1 (en)	2001-10-30	New uses of imidazolylmethyl-pyridines
AU2001274750A1 (en)	2002-01-02	Novel beta-hydroxyamides
AU2001284891A1 (en)	2002-02-25	Micronized leflunomide
AU2001279612A1 (en)	2002-03-04	Substituted polyamine compounds
AU2001260607A1 (en)	2001-12-03	Nitrile compounds and process for their preparation
AU2002221882A1 (en)	2002-06-03	Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors

Legal Events

Date	Code	Title	Description
2002-05-02	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
2002-07-18	TH	Corrigenda	Free format text: IN VOL 16, NO 12, PAGE(S) 2688-2711 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 45353/00, 78995/00, 56595/01, 65839/01, 65840/01, 66300/01, 13576/02